John Hussman's ANIP Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 52,500 shares of ANI Pharmaceuticals, Inc. (ANIP) worth $4.04 M, representing 0.87% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, John Hussman has maintained a strategic position in ANIP, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 31,500 shares. Largest reduction occurred in Q3 2024, reducing 42,000 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's ANI Pharmaceuticals (ANIP) Holding Value Over Time
Track share changes against reported price movement
Quarterly ANI Pharmaceuticals (ANIP) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +21,000 | Add 66.67% | 52,500 | $76.90 |
| Q4 2025 | +31,500 | New Buy | 31,500 | $78.94 |
| Q1 2025 | -31,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | +31,500 | New Buy | 31,500 | $55.28 |
| Q3 2024 | -42,000 | Sold Out | 0 | $0.00 |
| Q2 2024 | +10,500 | Add 33.33% | 42,000 | $63.68 |
| Q1 2024 | +31,500 | New Buy | 31,500 | $69.13 |
| Q3 2021 | -30,400 | Sold Out | 0 | $0.00 |
| Q4 2020 | -5,100 | Reduce 14.37% | 30,400 | $29.05 |
| Q3 2019 | +10,500 | Add 42.00% | 35,500 | $72.87 |
| Q2 2019 | +11,500 | Add 85.19% | 25,000 | $82.20 |
| Q1 2019 | -3,500 | Reduce 20.59% | 13,500 | $70.52 |
| Q3 2018 | +17,000 | New Buy | 17,000 | $56.53 |
John Hussman's ANI Pharmaceuticals Investment FAQs
John Hussman first purchased ANI Pharmaceuticals, Inc. (ANIP) in Q3 2018, acquiring 17,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held ANI Pharmaceuticals, Inc. (ANIP) for 20 quarters since Q3 2018.
John Hussman's largest addition to ANI Pharmaceuticals, Inc. (ANIP) was in Q1 2024, adding 31,500 shares worth $2.18 M.
According to the latest 13F filing for Q1 2026, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 52,500 shares of ANI Pharmaceuticals, Inc. (ANIP), valued at approximately $4.04 M.
As of the Q1 2026 filing, ANI Pharmaceuticals, Inc. (ANIP) represents approximately 0.87% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in ANI Pharmaceuticals, Inc. (ANIP) was 52,500 shares, as reported at the end of Q1 2026.